1109 related articles for article (PubMed ID: 27165816)
1. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
[TBL] [Abstract][Full Text] [Related]
2. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated rejection of single class I MHC-disparate cardiac allografts.
Hattori Y; Bucy RP; Kubota Y; Baldwin WM; Fairchild RL
Am J Transplant; 2012 Aug; 12(8):2017-28. PubMed ID: 22578247
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
[TBL] [Abstract][Full Text] [Related]
5. Acute humoral rejection of renal allografts in CCR5(-/-) recipients.
Bickerstaff A; Nozaki T; Wang JJ; Pelletier R; Hadley G; Nadasdy G; Nadasdy T; Fairchild RL
Am J Transplant; 2008 Mar; 8(3):557-66. PubMed ID: 18294152
[TBL] [Abstract][Full Text] [Related]
6. Recipient myeloperoxidase-producing cells regulate antibody-mediated acute versus chronic kidney allograft rejection.
Miyairi S; Ueda D; Yagisawa T; Okada D; Keslar KS; Tanabe K; Dvorina N; Valujskikh A; Baldwin WM; Hazen SL; Fairchild RL
JCI Insight; 2021 Jul; 6(13):. PubMed ID: 34081629
[TBL] [Abstract][Full Text] [Related]
7. Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.
Ishii D; Rosenblum JM; Nozaki T; Schenk AD; Setoguchi K; Su CA; Gorbacheva V; Baldwin WM; Valujskikh A; Fairchild RL
J Immunol; 2014 Oct; 193(7):3816-24. PubMed ID: 25172484
[TBL] [Abstract][Full Text] [Related]
8. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
[TBL] [Abstract][Full Text] [Related]
9. Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model.
Abe T; Ishii D; Gorbacheva V; Kohei N; Tsuda H; Tanaka T; Dvorina N; Nonomura N; Takahara S; Valujskikh A; Baldwin WM; Fairchild RL
Am J Transplant; 2015 May; 15(5):1192-204. PubMed ID: 25731734
[TBL] [Abstract][Full Text] [Related]
10. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
[TBL] [Abstract][Full Text] [Related]
11. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
12. Role of CXCR3 and CCR5 in allograft rejection.
Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
[TBL] [Abstract][Full Text] [Related]
13. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
[TBL] [Abstract][Full Text] [Related]
14. CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice.
Nozaki T; Rosenblum JM; Ishii D; Tanabe K; Fairchild RL
J Immunol; 2008 Oct; 181(8):5257-63. PubMed ID: 18832680
[TBL] [Abstract][Full Text] [Related]
15. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
Zhang QW; Kish DD; Fairchild RL
J Immunol; 2003 Jun; 170(11):5530-7. PubMed ID: 12759430
[TBL] [Abstract][Full Text] [Related]
16. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
17. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection.
Abdi R; Smith RN; Makhlouf L; Najafian N; Luster AD; Auchincloss H; Sayegh MH
Diabetes; 2002 Aug; 51(8):2489-95. PubMed ID: 12145162
[TBL] [Abstract][Full Text] [Related]
18. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
Yamada J; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cells Mediate Long-term Kidney Allograft Injury.
Zhang ZX; Huang X; Jiang J; Lau A; Yin Z; Liu W; Haig A; Jevnikar AM
Transplantation; 2015 May; 99(5):916-24. PubMed ID: 25719259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
